Filing Details
Dyne Therapeutics, Inc. (NASDAQ:DYN) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:DYN
Dyne Therapeutics, Inc. (DYN) Reports Material Event to SEC
Filing Details Dyne Therapeutics, Inc. (NASDAQ:DYN) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context Dyne…
Market Context
Dyne Therapeutics, Inc.'s stock currently trades at $23.45 with a market capitalization of $2.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Dyne Therapeutics, Inc.'s stock.
All SEC filings for Dyne Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DYN Stock Page
Frequently Asked Questions
Where can I read DYN's SEC filings?
Browse all filings on our DYN SEC filings page.
What types of SEC filings does Dyne Therapeutics, Inc. file?
Public companies like Dyne Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.